Convergence Pharmaceuticals
VerifiedFocused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$675m (Public information from Jan 2015)
Company register number 07289568
Babraham England (HQ)
Authorizing premium user...